Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Gene Therapy|August 21, 2015
CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targetingD G Courtney, J E Moore, S D Atkinson, et al.Journal of Neuroinflammation|March 1, 2024
Single-cell RNA sequencing reveals peripheral blood leukocyte responses to spinal cord injury in mice with humanised immune systemsEllen R Gillespie, Laura F Grice, Isabel G Courtney, et al.Nature Communications|February 7, 2026
Myoferlin is a component of late-stage vRNP trafficking vesicles for enveloped RNA virusesStefano Bonazza, Hannah L Turkington, Swathi Sukumar, et al.Journal of the American College of Radiology : JACR|June 1, 2024
ACR Appropriateness Criteria® Hydronephrosis on Prior Imaging-Unknown Cause, Pat Whitworth, Kelsey G Courtney, et al.Nucleic Acids Research|April 30, 2024
The RBPome of influenza A virus NP-mRNA reveals a role for TDP-43 in viral replicationMaud Dupont, Tim Krischuns, Quentin Giai Gianetto, et al.Investigative Ophthalmology & Visual Science|January 16, 2014
Development of allele-specific gene-silencing siRNAs for TGFBI Arg124Cys in lattice corneal dystrophy type IDavid G Courtney, Sarah D Atkinson, Johnny E Moore, et al.Viruses|February 26, 2022
Comparison of SARS-CoV-2 Evolution in Paediatric Primary Airway Epithelial Cell Cultures Compared with Vero-Derived Cell LinesConnor G G Bamford, Lindsay Broadbent, Elihu Aranday-Cortes, et al.Investigative Ophthalmology & Visual Science|May 8, 2014
siRNA silencing of the mutant keratin 12 allele in corneal limbal epithelial cells grown from patients with Meesmann's epithelial corneal dystrophyDavid G Courtney, Sarah D Atkinson, Edwin H A Allen, et al.Experimental Eye Research|October 27, 2018
A novel role for CRIM1 in the corneal response to UV and pterygium developmentEleonora Maurizi, Davide Schiroli, Sarah D Atkinson, et al.Expert Review of Gastroenterology & Hepatology|March 10, 2017
Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access programE Gray, A O'Leary, C Bergin, et al.Pageof 10